Identifying comparable diagnostic rates with our cohort of GJB2 carriers due to pathogenic variants in other ARHL genes highlights the large locus heterogeneity that drives nonsyndromic hearing loss and the substantial GJB2 carrier frequency in the general population. This evidence concerns the gene GJB2 and hearing loss disorder.